Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy Rothwell

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Journal of Pharmacokinetics and Pharmacodynamics|October 19, 2015
Study design and population pharmacokinetic analysis of a phase II dose-ranging study of interleukin-1 receptor antagonistKayode Ogungbenro, Sharon Hulme, Nancy Rothwell, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 5, 2002
Interleukin-1 influences ischemic brain damage in the mouse independently of the interleukin-1 type I receptorOmar Touzani, Herve Boutin, Rosalind LeFeuvre, et al.
European Radiology|November 7, 2008
Potential surrogate markers of cerebral microvascular angiopathy in asymptomatic subjects at risk of strokeJohann Selvarajah, Marietta Scott, Stavros Stivaros, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 17, 2015
AIM2 and NLRC4 inflammasomes contribute with ASC to acute brain injury independently of NLRP3Adam Denes, Graham Coutts, Nikolett Lénárt, et al.
European Journal of Medical Research|August 29, 2023
The role of cortisol in immunosuppression in subarachnoid haemorrhageMargaret E Hoadley, James Galea, Navneet Singh, et al.
Aging Cell|June 4, 2013
Aging aggravates ischemic stroke-induced brain damage in mice with chronic peripheral infectionHiramani Dhungana, Tarja Malm, Adam Denes, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|July 15, 2010
Intravenous anakinra can achieve experimentally effective concentrations in the central nervous system within a therapeutic time window: results of a dose-ranging studyJames Galea, Kayode Ogungbenro, Sharon Hulme, et al.
Cerebrovascular Diseases (Basel, Switzerland)|February 23, 2008
Improving outcome after stroke: overcoming the translational roadblockMatthias Endres, Britta Engelhardt, Jari Koistinaho, et al.
Journal of Neurosurgery|March 17, 2017
Reduction of inflammation after administration of interleukin-1 receptor antagonist following aneurysmal subarachnoid hemorrhage: results of the Subcutaneous Interleukin-1Ra in SAH (SCIL-SAH) studyJames Galea, Kayode Ogungbenro, Sharon Hulme, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2007
NF-kappaB activation by the Toll-IL-1 receptor domain protein MyD88 adapter-like is regulated by caspase-1Sinead M Miggin, Eva Pålsson-McDermott, Aisling Dunne, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Journal of Pharmacokinetics and Pharmacodynamics|October 19, 2015
Study design and population pharmacokinetic analysis of a phase II dose-ranging study of interleukin-1 receptor antagonistKayode Ogungbenro, Sharon Hulme, Nancy Rothwell, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 5, 2002
Interleukin-1 influences ischemic brain damage in the mouse independently of the interleukin-1 type I receptorOmar Touzani, Herve Boutin, Rosalind LeFeuvre, et al.
European Radiology|November 7, 2008
Potential surrogate markers of cerebral microvascular angiopathy in asymptomatic subjects at risk of strokeJohann Selvarajah, Marietta Scott, Stavros Stivaros, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 17, 2015
AIM2 and NLRC4 inflammasomes contribute with ASC to acute brain injury independently of NLRP3Adam Denes, Graham Coutts, Nikolett Lénárt, et al.
European Journal of Medical Research|August 29, 2023
The role of cortisol in immunosuppression in subarachnoid haemorrhageMargaret E Hoadley, James Galea, Navneet Singh, et al.
Aging Cell|June 4, 2013
Aging aggravates ischemic stroke-induced brain damage in mice with chronic peripheral infectionHiramani Dhungana, Tarja Malm, Adam Denes, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|July 15, 2010
Intravenous anakinra can achieve experimentally effective concentrations in the central nervous system within a therapeutic time window: results of a dose-ranging studyJames Galea, Kayode Ogungbenro, Sharon Hulme, et al.
Cerebrovascular Diseases (Basel, Switzerland)|February 23, 2008
Improving outcome after stroke: overcoming the translational roadblockMatthias Endres, Britta Engelhardt, Jari Koistinaho, et al.
Journal of Neurosurgery|March 17, 2017
Reduction of inflammation after administration of interleukin-1 receptor antagonist following aneurysmal subarachnoid hemorrhage: results of the Subcutaneous Interleukin-1Ra in SAH (SCIL-SAH) studyJames Galea, Kayode Ogungbenro, Sharon Hulme, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2007
NF-kappaB activation by the Toll-IL-1 receptor domain protein MyD88 adapter-like is regulated by caspase-1Sinead M Miggin, Eva Pålsson-McDermott, Aisling Dunne, et al.
Pageof 3